Advertisement · 728 × 90
#
Hashtag
#antitumor
Advertisement · 728 × 90
Post image

A #MonoclonalAntibody targeting mutant p53‑R175H shows high #antitumor activity, with enhanced efficacy when combined with anti‑PD‑1, highlighting DNA‑delivered antibodies as a strategy for #mutantp53‑driven #cancers. @bcmhouston.bsky.social
#OpenAccess: doi.org/10.1016/j.ge...

0 0 0 0
Post image

#Bcl6 inhibition destabilizes #TregCells by reducing H3K4me3, enhancing #AntiTumor immunity, delaying #HeadandNeckSquamousCellCarcinoma progression, and synergizing with immune checkpoint therapy, highlighting Bcl6 as a promising target.

#OpenAccess: doi.org/10.1016/j.ge...

1 1 0 0
Post image

Researchers from @uclacollege.bsky.social use spatiotemporal analyses to compare the #AntiTumor response of CAR-T & CAR-NKT cells in #SolidTumors, revealing differences in immune-cell dynamics, tumor infiltration, and checkpoint regulation.

#OpenAccess: doi.org/10.1038/s413...

0 0 0 0
Post image

❓Tech Q&A | Niraparib HCl has #antitumor activity and shows some cytotoxicity
🔸At appropriate concentrations, it typically does not add extra toxicity to normal cells
🔸Can be used directly as a #PARP inhibitor after dissolution, no desalting required

#PARPInhibitor #CancerResearch #CellBiology

1 0 0 0
Preview
A Novel Peptide, HS1002, Enhances Antitumor Activity via Dual Targeting of the GnRH Receptor and Human Telomerase Reverse Transcriptase in Prostate Cancer Cells HS1002, a new peptide targeting GnRHR and hTERT, demonstrates significant Anticancer activity in prostate cancer cells. The mechanism of HS1002 can be attributed to the reduction of serum testosteron...

#Article in #MedComm

A Novel #Peptide, #HS1002, Enhances #Antitumor Activity via Dual Targeting of the #GnRH Receptor and Human #Telomerase Reverse Transcriptase in Prostate Cancer Cells doi.org/10.1002/mco2...

Research team from Sungkyunkwan University

#hTERT #ImmuneResponse #ProstateCancer

0 0 0 0
Key Genes Involved in the Beneficial Mechanism of Hyperbaric Oxygen for Glioblastoma and Predictive Indicators of Hyperbaric Oxygen Prolonging Survival in Glioblastoma Patients

Key Genes Involved in the Beneficial Mechanism of Hyperbaric Oxygen for Glioblastoma and Predictive Indicators of Hyperbaric Oxygen Prolonging Survival in Glioblastoma Patients

This study shows that #HBOTherapy exerts #Antitumor effects in #Glioblastoma, promoting #Apoptosis, inhibiting #Inflammation, reducing #CellProliferation, suppressing #TumorGrowth & #Metastasis, regulating #Vascularization, & thus prolonging patient survival. #medsky

Read: doi.org/10.1007/s115...

1 0 0 0
Post image

A bimetallic triple-kill nanobomb system (MnO₂/Co-DA@BiTE/HPT) synergistically enhances BiTE efficacy against #ColorectalCancer by activating the STING pathway via #PhotothermalTherapy, to promote robust #AntiTumor immunity.

#STTT #OpenAccess: doi.org/10.1038/s413...

2 0 0 1
Michael Acceptor Pyrrolidone Derivatives and Their Activity against Diffuse Large B-cell Lymphoma

Michael Acceptor Pyrrolidone Derivatives and Their Activity against Diffuse Large B-cell Lymphoma

In this study, the researchers spotlight the #Antitumor potential of variant 7 among synthesized pyrrolidone compounds in #DLBCL cell lines, which induces #DNAdamage, #Inflammatory responses, #CellCycle arrest, & #Apoptosis. #medsky

To read: doi.org/10.1007/s115...

0 0 0 0
Post image

CXCR4hi #CARTcells boost #TumorTracking, #BoneMarrow homing, and persistence, enhancing #Antitumor activity; early trial data in B cell malignancies show multiple complete responses, supporting #CXCR4 modification.

#OpenAccess in #STTT: doi.org/10.1038/s413...

1 0 0 0

🗝️ Tor und 🏰 Schlüssel zur Wirkung von 🌱 #Cannabis 06

mastodon.social/@Karl_Theodor/1161308336...

#Immunsystem #antiTumor #cancer #Krebs #hanf #hemp #marijuana #Hanf_heilt #Hanfwissen #healing #health #Gesundheit #Medizin #Wissenschaft #Forschung

0 1 0 0
Anti-MSLN chimeric antigen receptor-like NK cell therapy with tumor-penetrating capacity (uCAR-like NK) for solid tumors

Anti-MSLN chimeric antigen receptor-like NK cell therapy with tumor-penetrating capacity (uCAR-like NK) for solid tumors

Anti-mesothelin uCAR-like #NaturalKiller cells integrating #tumor-penetrating #peptides show enhanced targeting, infiltration, & superior #antitumor efficacy, establishing a modular nongenetic NK platform for MSLN-positive #SolidTumorTherapy.
#OpenAccess #STTT: doi.org/10.1038/s413...

1 0 0 0
Post image

SHR-1701 plus nab-paclitaxel and #gemcitabine show promising #antitumor activity with manageable safety in advanced #PancreaticCancer, while PD-L1 status and #biomarkers such as CA19-9 predict improved survival outcomes. @fudan-university.bsky.social

#STTT: doi.org/10.1038/s413...

0 0 0 0
Post image

Scientists show that engineering #CARTcells to overexpress #CXCR4 restores #CXCL12-guided migration, enhances #tumortracking and #BoneMarrow homing, promotes memory persistence, and improves #antitumor efficacy in #BcellLymphoma and #myeloma.

#STTT: doi.org/10.1038/s413...

2 0 0 0
HSD17B12 interacts with PD-L1 in living cells.Top: PD-L1 partially colocalizes with HSD17B12 in A375 cells. Representative images are shown (scale bars: 5 μm). Immunofluorescence staining was performed using anti-PD-L1 and anti-HSD17B12 antibodies. Bottom: Schematic model showing membrane localization of HSD17B12.

HSD17B12 interacts with PD-L1 in living cells.Top: PD-L1 partially colocalizes with HSD17B12 in A375 cells. Representative images are shown (scale bars: 5 μm). Immunofluorescence staining was performed using anti-PD-L1 and anti-HSD17B12 antibodies. Bottom: Schematic model showing membrane localization of HSD17B12.

#Cancer #immunotherapy faces widespread resistance via mechanisms like PD-L1 suppression. This study identifies the metabolic enzyme HSD17B12 as a regulator of PD-L1 degradation, showing that an HSD17B12-derived peptide boosts #AntiTumor #immunity in a mouse model @plosbiology.org 🧪 plos.io/4k2rtyR

5 0 0 0
HSD17B12 interacts with PD-L1 in living cells.Top: PD-L1 partially colocalizes with HSD17B12 in A375 cells. Representative images are shown (scale bars: 5 μm). Immunofluorescence staining was performed using anti-PD-L1 and anti-HSD17B12 antibodies. Bottom: Schematic model showing membrane localization of HSD17B12.

HSD17B12 interacts with PD-L1 in living cells.Top: PD-L1 partially colocalizes with HSD17B12 in A375 cells. Representative images are shown (scale bars: 5 μm). Immunofluorescence staining was performed using anti-PD-L1 and anti-HSD17B12 antibodies. Bottom: Schematic model showing membrane localization of HSD17B12.

#Cancer #immunotherapy faces widespread resistance via mechanisms like PD-L1 suppression. This study identifies the metabolic enzyme HSD17B12 as a regulator of PD-L1 degradation, showing that an HSD17B12-derived peptide boosts #AntiTumor #immunity in a mouse model @plosbiology.org 🧪 plos.io/4k2rtyR

7 2 0 0
HSD17B12 interacts with PD-L1 in living cells.Top: PD-L1 partially colocalizes with HSD17B12 in A375 cells. Representative images are shown (scale bars: 5 μm). Immunofluorescence staining was performed using anti-PD-L1 and anti-HSD17B12 antibodies. Bottom: Schematic model showing membrane localization of HSD17B12.

HSD17B12 interacts with PD-L1 in living cells.Top: PD-L1 partially colocalizes with HSD17B12 in A375 cells. Representative images are shown (scale bars: 5 μm). Immunofluorescence staining was performed using anti-PD-L1 and anti-HSD17B12 antibodies. Bottom: Schematic model showing membrane localization of HSD17B12.

#Cancer #immunotherapy faces widespread resistance via mechanisms like PD-L1 suppression. This study identifies the metabolic enzyme HSD17B12 as a regulator of PD-L1 degradation, showing that an HSD17B12-derived peptide boosts #AntiTumor #immunity in a mouse model @plosbiology.org 🧪 plos.io/4k2rtyR

5 3 0 0
Post image

An open-label, single-arm, phase II #ClinicalTrial assessing the efficacy of #Sintilimab + #Anlotinib revealed promising #AntiTumor effect and safety profile in treatment-naïve #Metastatic #ColorectalCancer (mCRC) patients.

#OpenAccess: doi.org/10.1038/s413...

0 0 0 0

New publication: "Trastuzumab-Conjugated pH-Sensitive Micelles Exhibit #Antitumor Activity and Induce Mesenchymal-to-Epithelial Transition in Triple-Negative Breast #Cancer Cell Lines" with Kirsten Sandvig from @biovitenskap.bsky.social , published in #Pharmaceutics by @mdpiopenaccess.bsky.social

0 0 0 0
Post image

📰New & Featured | #Cell: #GPX4 released during #ferroptosis binds to dendritic #ZP3, activating cAMP-PPKA signaling
🔸Inhibits #glycolysis
🔸Impairs DC maturation and activation
🔸Eventually results in T cell priming defect
🧐Blocking GPX4-ZP3 interaction potentially drives #antitumor activity

0 0 0 0
Post image

Researchers develop a #PSMA‑targeted self‑assembling nano‑PROTAC that simultaneously degrades AR, AR‑V7, and HSP90 in #CRPC, overcoming resistance to AR inhibitors, achieving potent #antitumor activity with tumor‑specific accumulation.

#OpenAccess in #STTT: doi.org/10.1038/s413...

2 2 0 0
Preview
Inhibition of RNA-binding proteins enhances immunotherapy in ovarian cancer - Signal Transduction and Targeted Therapy Signal Transduction and Targeted Therapy - Inhibition of RNA-binding proteins enhances immunotherapy in ovarian cancer

Scientists identify #IGF2BP1 as a driver of #ImmuneEvasion in C5 #OvarianCancer, suppressing IFN‑γ–IRF1–MHC‑I signaling and T‑cell infiltration; its inhibition restores #antitumor immunity and boosts #PD1blockade. @unihalle.bsky.social

#OpenAccess in #STTT: doi.org/10.1038/s413...

3 1 0 1
Preview
Dysadherin/YAP axis fuels stem plasticity and immune escape in liver cancer - Signal Transduction and Targeted Therapy Signal Transduction and Targeted Therapy - Dysadherin/YAP axis fuels stem plasticity and immune escape in liver cancer

Scientists identify #Dysadherin as an upstream activator of the FAK/YAP/TEAD2 axis in #HCC, showing it drives #CancerStemness and #ImmuneEvasion, while genetic or peptide inhibition restores #antitumor immunity and improves therapy response.

#OpenAccess #STTT: doi.org/10.1038/s413...

1 0 0 0
Preview
Non‐stoichiometric Sodium Chloride Reprograms Ionic Homeostasis to Enhance Antitumor Immunity Click on the article title to read more.

#Letter in #MedComm
Non-stoichiometric Sodium Chloride Reprograms Ionic Homeostasis to Enhance Antitumor Immunity doi.org/10.1002/mco2...

#TME #DendriticCell #ExtracellularPotassium #Ionic #Homeostasis #Antitumor #Immunity

0 0 0 0
Post image

A review on the #AntiTumor mechanisms of high-dose #VitaminC, detailing preclinical & clinical studies investigating its #AntiCancer role, advancements in high-dose vitamin C therapy for #Cancer treatment, and directions for future research.

#OpenAccess: doi.org/10.1016/j.ge...

0 0 0 0
Post image

An open-label, single-arm, phase II #ClinicalTrial of #Sintilimab + #Anlotinib in treatment-naïve #Metastatic #ColorectalCancer patients showed promising #Antitumor efficacy & a tolerable safety profile.

#STTT #OpenAccess: doi.org/10.1038/s413...

0 0 0 0
Post image

#Neutrophil-targeted #STAT3 inhibition reshapes #neutrophils into #antitumor effectors, suppresses tumor growth, and boosts cytotoxic CD8⁺ T-cell activity, highlighting STAT3 blockade as a promising #CancerImmunotherapy strategy. @unidue.bsky.social

#STTT: doi.org/10.1038/s413...

1 0 0 0
Post image

EpsteinBarrVirus upregulates KDM5B via EBNA1 and BZLF1, driving #EpithelialCancer progression through PLK2 demethylation and PI3K/AKT/mTOR activation, while KDM5B inhibition delivers strong #AntiTumor effects. #medsky

#OpenAccess in #STTT: doi.org/10.1038/s413...

2 1 0 0
Post image

Join us next week for an episode with Dr. Ana Anderson from Harvard Medical School!

Her research focuses on understanding the pathways and mechanisms that regulate the #AntiTumor immune response.

6 3 0 0
Preview
Marine bacteria show potent antitumor effects against colorectal cancer A research team led by Professor Eijiro Miyako at the Graduate School of Advanced Science and Technology, Japan Advanced Institute of Science and Technology (JAIST), has discovered that the marine…

#Marine #bacteria show potent #antitumor effects against #colorectal #cancer ...

| #Photobacterium | #lysis | #tumor | #therapy | Via @sciencex.bsky.social

0 0 0 0
Post image

#Mesothelin-targeted CAR-NK cells secreting the IL-2Rβγ agonist neo-2/15 sustain IL-2 signaling, boost c-Myc/NRF1-driven metabolism, resist TME-induced exhaustion, and exhibit stronger #AntiTumor activity and persistence in #SolidTumors.

#STTT #OpenAccess: doi.org/10.1038/s413...

0 0 0 0